Key result
Recent advances in genetics, imaging, and therapies update the management of adult adrenocortical carcinoma.
Why the study?
Adrenocortical carcinoma is a rare and aggressive malignancy with poor 5-year survival and limited effective therapies, and large cohort studies were lacking until recent international collaborations.
Population
Adults with adrenocortical carcinoma
Comparison
Recent advances in genetic, hormonal evaluation, imaging, and therapies versus previous approaches
Design
Review of recent international and multicenter studies
Authors
Loading...
Collaborative ACC data refine risk stratification and multimodal care; leaves open prospective validation of biomarkers and targeted therapies.
This review summarizes recent advances in the diagnosis and management of adrenocortical carcinoma, highlighting new imaging modalities and therapeutic approaches.
Bourdeau et al. (2013) conducted a review in Adrenocortical carcinoma. Recent collaborative studies and advances in genetics, imaging, and therapies provide new evidence-based insights for the management of adrenocortical carcinoma in adults.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: